Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1993-04-02
1996-02-20
Parr, Margaret Moskowitz
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303877, 5303897, 5303911, 5303915, 935 15, 4241311, 4241381, 4241551, 4241781, 424 932, 536 2353, 4351722, 43524027, 435 7021, 435965, A61K 39395, C07K 1628, C07K 1642, C12N 516
Patent
active
054930090
ABSTRACT:
The invention concerns murine antiidiotypic monoclonal antibodies which are the internal image of determinants recognized by a monoclonal antibody on high molecular weight-melanoma associated antigen (HMW-MAA), antibody derivatives, hybridoma cell lines secreting such antiidiotypic monoclonal antibodies, and processes for the preparation of such antiidiotypic monoclonal antibodies, of their derivatives and of the hybridoma cell lines. The murine antiidiotypic monoclonal antibodies are useful for the determination of antibodies directed against high molecular weight-melanoma associated antigen, for the modulation of the immune response to HMW-MAA and for the treatment of melanoma.
REFERENCES:
patent: 4918164 (1990-04-01), Hellstrom et al.
Giacomini et al., "Analysis Of The Interaction Between A Human High Molecular Weight Melanoma-Associated Antigen And The Monoclonal Antibodies To Three Distinct Antigenic Determinants", The Journal of Immunology, vol. 135, No. 1, pp. 696-702 (Jul. 1985).
Koprowski et al., "Human Anti-idiotype Antibodies In Cancer Patients: Is The Modulation Of The Immune Response Beneficial For The Patient?", Proc. Natl. Acad. Sci. USA, vol. 81, pp. 216-219 (Jan. 1984).
Kusama et al., "Syngeneic Monoclonal Antiidiotypic Antibodies To Murine Anti Human High Molecular Weight-Melanoma Associated Antigen Monoclonal Antibodies", Monoclonals and DNA Probes in Diagnostic and Preventive Medicine, pp. 101-110, Raven Press, New York (1987).
Kusama et al., "Antiidiotypic Monoclonal Antibodies To Anti Human High Molecular Weight-Melanoma Associated Antigen Monoclonal Antibodies", Proceedings of AACR, vol. 28, p. 361 (Mar. 1987).
Kusama et al., "Syngeneic Antiidiotypic Antisera To Murine Antihuman High-Molecular-Weight Melanoma-associated Antigen Monoclonal Antibodies", Cancer Research, vol. 47, pp. 4312-4317 (Aug. 15, 1987).
Mittelman et al., "A Phase I Clinical Trial of Murine Anti-Idiotypic Monoclonal Antibodies To Anti Human High Molecular Weight--Melanoma Associated Antigen Monoclonal Antibodies In Patients With Malignant Melanoma", Proceedings of AACR, vol. 28, P. 390 (Mar. 1987).
Nepom et al., "Induction of Immunity To A Human Tumor Marker By In Vivo Administration of Anti-idiotypic Antibodies In Mice", Proc. Natl. Acad. Sci. USA, vol. 81, pp. 2864-2867 (May 1984).
Tsujisaki et al., "A Sandwich Assay To Detect And Characterize Syngeneic Anti-idiotypic Antibodies To Murine Anti-HLA And Tumor Associated Antigen Monoclonal Antibodies", Journal of Immunological Methods, vol. 95, pp. 47-55 (1986).
Tsujisaki et al., "Syngeneic Polyclonal And Monoclonal Anti-idiotypic Antibodies To Murine Anti-Human High Molecular Weight-Melanoma Associated Antigen And Anti-HLA Monoclonal Antibodies", in: Cellular, Molecular And Genetic Approaches To Immunodiagnosis And Immunotherapy, K. Kano et al. (eds.), Karger, Basel, pp. 251-258 (1987).
Paul et al., Fundamental Immunology, 2nd. ed. (1989) Chapt. 36, pp. 1014-1016, "Anti-Idiotypic Antibody".
Hird et al., Gene and Cancer: Chapt. 17 "Immunotherapy w/ Mono. Anti.", pp. 183-189 (1990).
Osband et al., Immunol. Today, 11(6):193-195 (1990) "Problems in . . . Cancer Immun.".
Waldmann, Science, 252:1657-1662 (1991) "MAb in Diagnosis & Therapy".
Dillmann, Annals of Int. Med. 111:592-602 (1989), "MAb in Treating Cancer".
Moskowitz Parr Margaret
New York Medical College
Nisbet T. Michael
LandOfFree
Antiidiotypic monoclonal antibodies MK2-23 anti-melanomal antibo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiidiotypic monoclonal antibodies MK2-23 anti-melanomal antibo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiidiotypic monoclonal antibodies MK2-23 anti-melanomal antibo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1356936